Conference
DULAGLUTIDE REDUCES HBA1C IRRESPECTIVE OF ANTIHYPERGLYCEMIC AGENTS, DURATION OF DIABETES, BMI AND WEIGHT LOSS: A POST HOC ANALYSIS FROM THE REWIND TRIAL
Authors
Kwan A; Gerstein H; Xavier D; Basile J; Maldonado J; Raha S; Konig M
Volume
75
Publisher
Elsevier
Publication Date
March 24, 2020
DOI
10.1016/s0735-1097(20)32578-x
Conference proceedings
Journal of the American College of Cardiology
Issue
11
ISSN
0735-1097